United States Healthcare Equipment & Supplies

ICU Medical, Inc. (ICUI)

Track

Track

ICU Medical experienced significant insider selling over the past ninety days, totaling over thirteen million dollars. Executives, including the CFO and General Counsel, executed twenty-one transactions, primarily through planned divestments. This activity follows a positive earnings report in August, while the stock price has appreciated twelve percent during this period.
Ticker: ICUI Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for ICU Medical, Inc.. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.5
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Planned sale
Price
238.43
Quantity 37,422 +36.7%
Value US$4,573,833
2.5
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Planned sale
Price
86.46
Quantity 78,183 -27.8%
Value US$3,187,765
2.5
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Planned sale
Price
448.55
Quantity 38,688 -2.4%
Value US$1,715,181
2.5
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Planned sale
Price
167.67
Quantity 2,202 -11.3%
Value US$369,203
2.5
VIRGINIA SANZONE Officer Officer
Transaction date
Proposed sale
Price
168.69
Quantity 4,856
Value US$819,150
Bonnell Brian Michael Chief Financial Officer Officer
Transaction date
Planned sale
Price
175.00
Quantity 6,381 -10.2%
Value US$1,116,675
BRIAN BONNELL Officer Officer
Transaction date
Proposed sale
Price
175.00
Quantity 6,381
Value US$1,116,675
Bonnell Brian Michael Chief Financial Officer Officer
Transaction date
Planned sale
Price
173.91
Quantity 1,113 -1.8%
Value US$193,567
Bonnell Brian Michael Chief Financial Officer Officer
Transaction date
Planned sale
Price
173.44
Quantity 4,568 -6.7%
Value US$792,291
Bonnell Brian Michael Chief Financial Officer Officer
Transaction date
Planned sale
Price
172.12
Quantity 1,914 -2.7%
Value US$329,443
Bonnell Brian Michael Chief Financial Officer Officer
Transaction date
Planned sale
Price
171.05
Quantity 1,712 -2.4%
Value US$292,843
BRIAN BONNELL Officer Officer
Transaction date
Proposed sale
Price
172.79
Quantity 9,307
Value US$1,608,143
3.0
Woolson Daniel VP, GM-Infusion Capital Officer
Transaction date
Sale
Price
181.33
Quantity 5,417 -24.1%
Value US$982,265
3.0
DANIEL WOOLSON Officer Officer
Transaction date
Proposed sale
Price
181.33
Quantity 5,417
Value US$982,265
2.4
Sousa Ben Chief Information Officer Officer
Transaction date
Sale
Price
178.32
Quantity 2,250 -42.2%
Value US$401,209
2.4
BENJAMIN SOUSA Officer Officer
Transaction date
Proposed sale
Price
178.32
Quantity 2,250
Value US$401,209
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
182.93
Quantity 8,929 -19.3%
Value US$1,633,404
3.3
FINNEY ELISHA W Non-Executive Director
Transaction date
Sale
Price
182.48
Quantity 378 -7.2%
Value US$68,978
3.4
CHRISTIAN VOIGTLANDER Officer Officer
Transaction date
Proposed sale
Price
182.93
Quantity 8,929
Value US$1,633,404
3.3
ELISHA W FINNEY Director Non-Executive Director
Transaction date
Proposed sale
Price
182.48
Quantity 378
Value US$68,978
3.3
ELISHA W FINNEY Director Non-Executive Director
Transaction date
Proposed sale
Price
182.48
Quantity 378
Value US$68,978
3.0
DANIEL WOOLSON Officer Officer
Transaction date
Proposed sale
Price
132.21
Quantity 2,123
Value US$280,685
3.0
Woolson Daniel President Officer
Transaction date
Sale
Price
132.21
Quantity 2,123 -8.6%
Value US$280,685
2.5
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Sale
Price
124.08
Quantity 2,447 -11.2%
Value US$303,624
2.5
VIRGINIA SANZONE Officer Officer
Transaction date
Proposed sale
Price
124.08
Quantity 2,447
Value US$303,624
1.8
Greenberg David C. Non-Executive Director
Transaction date
Sale
Price
122.91
Quantity 2,424 -23.3%
Value US$297,934
1.8
DAVID C GREENBERG Director Non-Executive Director
Transaction date
Proposed sale
Price
122.91
Quantity 2,424
Value US$297,934
3.0
DANIEL WOOLSON Officer Officer
Transaction date
Proposed sale
Price
152.35
Quantity 2,897
Value US$441,364
3.0
Woolson Daniel VP, GM-Infusion Capital Officer
Transaction date
Sale
Price
152.35
Quantity 2,897 -20.4%
Value US$441,364
2.5
VIRGINIA SANZONE Officer Officer
Transaction date
Proposed sale
Price
142.35
Quantity 930
Value US$132,381
3.3
ELISHA W FINNEY Director Non-Executive Director
Transaction date
Proposed sale
Price
140.42
Quantity 1,285
Value US$180,440
2.5
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Sale
Price
142.35
Quantity 930 -14.6%
Value US$132,381
3.3
FINNEY ELISHA W Non-Executive Director
Transaction date
Sale
Price
140.42
Quantity 1,285 -24.3%
Value US$180,440
1.8
Greenberg David C. Non-Executive Director
Transaction date
Purchase
Price
126.69
Quantity 598 +8.1%
Value US$75,760
1.8
Greenberg David C. Non-Executive Director
Transaction date
Purchase
Price
126.14
Quantity 602 +8.9%
Value US$75,938
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Purchase
Price
112.92
Quantity 19,551 +17.7%
Value US$2,207,761
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Purchase
Price
112.12
Quantity 2,378 +2.2%
Value US$266,613
2.5
VIRGINIA SANZONE Officer Officer
Transaction date
Proposed sale
Price
133.62
Quantity 700
Value US$93,537
2.5
Sanzone Virginia Ruth VP, General Counsel Officer
Transaction date
Sale
Price
133.62
Quantity 700 -9.9%
Value US$93,537
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
128.50
Quantity 4,985 -45.0%
Value US$640,576
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
131.00
Quantity 4,945 -47.3%
Value US$647,795
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
130.00
Quantity 4,959 -50.3%
Value US$644,670
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
130.03
Quantity 4,959 -53.5%
Value US$644,832
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
133.00
Quantity 4,917 -57.0%
Value US$653,961
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
137.11
Quantity 4,871 -61.3%
Value US$667,879
3.3
FINNEY ELISHA W Non-Executive Director
Transaction date
Sale
Price
138.92
Quantity 600 -15.6%
Value US$83,353
3.3
FINNEY ELISHA W Director Non-Executive Director
Transaction date
Proposed sale
Price
138.92
Quantity 600
Value US$83,353
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
138.00
Quantity 5,555 -69.9%
Value US$766,614
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
140.00
Quantity 5,555 -69.9%
Value US$777,700
2.4
Sousa Ben Officer Officer
Transaction date
Proposed sale
Price
137.36
Quantity 2,000
Value US$274,714
2.4
Sousa Ben Chief Information Officer Officer
Transaction date
Sale
Price
137.36
Quantity 2,000 -80.7%
Value US$274,714
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
135.55
Quantity 5,555 -69.9%
Value US$752,977
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
138.65
Quantity 5,556 -69.9%
Value US$770,324
3.4
Voigtlander Christian B. Officer Officer
Transaction date
Proposed sale
Price
138.65
Quantity 55,556
Value US$7,702,684
1.8
Greenberg David C. Director Non-Executive Director
Transaction date
Proposed sale
Price
143.66
Quantity 1,942
Value US$278,992
1.8
Greenberg David C. Non-Executive Director
Transaction date
Sale
Price
143.66
Quantity 1,942 -22.3%
Value US$278,992
4.0
VIVEK JAIN Officer; Director Executive Director
Transaction date
Proposed sale
Price
155.48
Quantity 1,373
Value US$213,474
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
155.48
Quantity 1,373 -1.3%
Value US$213,474
3.0
Woolson Daniel Officer Officer
Transaction date
Proposed sale
Price
156.25
Quantity 2,241
Value US$350,158
3.0
Woolson Daniel VP, GM-Infusion Capital Officer
Transaction date
Sale
Price
156.25
Quantity 2,241 -17.1%
Value US$350,158
4.0
VIVEK JAIN Officer; Director Executive Director
Transaction date
Proposed sale
Price
162.91
Quantity 12,000
Value US$1,954,933
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
163.96
Quantity 78 -0.1%
Value US$12,789
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
163.18
Quantity 8,250 -7.3%
Value US$1,346,223
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
162.29
Quantity 3,672 -3.1%
Value US$595,923
1.8
Greenberg David C. Director Non-Executive Director
Transaction date
Proposed sale
Price
158.11
Quantity 972
Value US$153,683
1.8
Greenberg David C. Non-Executive Director
Transaction date
Sale
Price
158.11
Quantity 972 -16.2%
Value US$153,683
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
158.00
Quantity 1,430 -100.0%
Value US$225,936
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
160.09
Quantity 206 -100.0%
Value US$32,979
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
159.09
Quantity 7,513 -97.3%
Value US$1,195,212
3.4
Voigtlander Christian B. Chief Operating Officer Officer
Transaction date
Sale
Price
169.08
Quantity 1,962 -100.0%
Value US$331,726
3.4
Voigtlander Christian B. Officer Officer
Transaction date
Proposed sale
Price
171.00
Quantity 11,111
Value US$1,899,981
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
173.60
Quantity 1,239 -1.2%
Value US$215,087
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
172.76
Quantity 2,386 -2.2%
Value US$412,212
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
171.91
Quantity 4,147 -3.7%
Value US$712,905
4.0
Jain Vivek Chairman and CEO Executive Director
Transaction date
Planned sale
Price
170.75
Quantity 4,228 -3.6%
Value US$721,933
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-03 2026-09-03 PlS Planned sale
2.5
Sanzone Virginia Ruth

VP, General Counsel

Officer
37,422 +36.7%
238.43
US$4,573,833 		37,422 +36.7% 238.43 US$4,573,833
2026-09-03 2026-09-03 PlS Planned sale
2.5
Sanzone Virginia Ruth

VP, General Counsel

Officer
78,183 -27.8%
86.46
US$3,187,765 		78,183 -27.8% 86.46 US$3,187,765
2026-09-03 2026-09-03 PlS Planned sale
2.5
Sanzone Virginia Ruth

VP, General Counsel

Officer
38,688 -2.4%
448.55
US$1,715,181 		38,688 -2.4% 448.55 US$1,715,181
2026-09-03 2026-09-03 PlS Planned sale
2.5
Sanzone Virginia Ruth

VP, General Counsel

Officer
2,202 -11.3%
167.67
US$369,203 		2,202 -11.3% 167.67 US$369,203
2026-09-03 2026-09-03 PrS Proposed sale
2.5
VIRGINIA SANZONE

Officer

Officer
4,856
168.69
US$819,150 		4,856 168.69 US$819,150
2026-09-01 2026-09-01 PlS Planned sale
Bonnell Brian Michael

Chief Financial Officer

Officer
6,381 -10.2%
175.00
US$1,116,675 		6,381 -10.2% 175.00 US$1,116,675
2026-09-01 2026-09-01 PrS Proposed sale
BRIAN BONNELL

Officer

Officer
6,381
175.00
US$1,116,675 		6,381 175.00 US$1,116,675
2026-08-31 2026-08-31 PlS Planned sale
Bonnell Brian Michael

Chief Financial Officer

Officer
1,113 -1.8%
173.91
US$193,567 		1,113 -1.8% 173.91 US$193,567
2026-08-31 2026-08-31 PlS Planned sale
Bonnell Brian Michael

Chief Financial Officer

Officer
4,568 -6.7%
173.44
US$792,291 		4,568 -6.7% 173.44 US$792,291
2026-08-31 2026-08-31 PlS Planned sale
Bonnell Brian Michael

Chief Financial Officer

Officer
1,914 -2.7%
172.12
US$329,443 		1,914 -2.7% 172.12 US$329,443
2026-08-31 2026-08-31 PlS Planned sale
Bonnell Brian Michael

Chief Financial Officer

Officer
1,712 -2.4%
171.05
US$292,843 		1,712 -2.4% 171.05 US$292,843
2026-08-31 2026-08-31 PrS Proposed sale
BRIAN BONNELL

Officer

Officer
9,307
172.79
US$1,608,143 		9,307 172.79 US$1,608,143
2026-08-13 2026-08-13 S Sale
3.0
Woolson Daniel

VP, GM-Infusion Capital

Officer
5,417 -24.1%
181.33
US$982,265 		5,417 -24.1% 181.33 US$982,265
2026-08-13 2026-08-13 PrS Proposed sale
3.0
DANIEL WOOLSON

Officer

Officer
5,417
181.33
US$982,265 		5,417 181.33 US$982,265
2026-08-12 2026-08-12 S Sale
2.4
Sousa Ben

Chief Information Officer

Officer
2,250 -42.2%
178.32
US$401,209 		2,250 -42.2% 178.32 US$401,209
2026-08-12 2026-08-12 PrS Proposed sale
2.4
BENJAMIN SOUSA

Officer

Officer
2,250
178.32
US$401,209 		2,250 178.32 US$401,209
2026-08-11 2026-08-11 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
8,929 -19.3%
182.93
US$1,633,404 		8,929 -19.3% 182.93 US$1,633,404
2026-08-11 2026-08-11 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
378 -7.2%
182.48
US$68,978 		378 -7.2% 182.48 US$68,978
2026-08-11 2026-08-11 PrS Proposed sale
3.4
CHRISTIAN VOIGTLANDER

Officer

Officer
8,929
182.93
US$1,633,404 		8,929 182.93 US$1,633,404
2026-08-11 2026-08-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
378
182.48
US$68,978 		378 182.48 US$68,978
2026-08-11 2026-08-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
378
182.48
US$68,978 		378 182.48 US$68,978
2026-05-22 2026-05-22 PrS Proposed sale
3.0
DANIEL WOOLSON

Officer

Officer
2,123
132.21
US$280,685 		2,123 132.21 US$280,685
2026-05-22 2026-05-22 S Sale
3.0
Woolson Daniel

President

Officer
2,123 -8.6%
132.21
US$280,685 		2,123 -8.6% 132.21 US$280,685
2026-05-15 2026-05-14 S Sale
2.5
Sanzone Virginia Ruth

VP, General Counsel

Officer
2,447 -11.2%
124.08
US$303,624 		2,447 -11.2% 124.08 US$303,624
2026-05-14 2026-05-14 PrS Proposed sale
2.5
VIRGINIA SANZONE

Officer

Officer
2,447
124.08
US$303,624 		2,447 124.08 US$303,624
2026-05-13 2026-05-12 S Sale
1.8
Greenberg David C.
Non-Executive Director
2,424 -23.3%
122.91
US$297,934 		2,424 -23.3% 122.91 US$297,934
2026-05-12 2026-05-12 PrS Proposed sale
1.8
DAVID C GREENBERG

Director

Non-Executive Director
2,424
122.91
US$297,934 		2,424 122.91 US$297,934
2025-11-25 2025-11-25 PrS Proposed sale
3.0
DANIEL WOOLSON

Officer

Officer
2,897
152.35
US$441,364 		2,897 152.35 US$441,364
2025-11-25 2025-11-25 S Sale
3.0
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,897 -20.4%
152.35
US$441,364 		2,897 -20.4% 152.35 US$441,364
2025-11-12 2025-11-11 PrS Proposed sale
2.5
VIRGINIA SANZONE

Officer

Officer
930
142.35
US$132,381 		930 142.35 US$132,381
2025-11-12 2025-11-11 PrS Proposed sale
3.3
ELISHA W FINNEY

Director

Non-Executive Director
1,285
140.42
US$180,440 		1,285 140.42 US$180,440
2025-11-12 2025-11-11 S Sale
2.5
Sanzone Virginia Ruth

VP, General Counsel

Officer
930 -14.6%
142.35
US$132,381 		930 -14.6% 142.35 US$132,381
2025-11-12 2025-11-11 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
1,285 -24.3%
140.42
US$180,440 		1,285 -24.3% 140.42 US$180,440
2025-08-27 2025-08-27 B Purchase
1.8
Greenberg David C.
Non-Executive Director
598 +8.1%
126.69
US$75,760 		598 +8.1% 126.69 US$75,760
2025-08-27 2025-08-27 B Purchase
1.8
Greenberg David C.
Non-Executive Director
602 +8.9%
126.14
US$75,938 		602 +8.9% 126.14 US$75,938
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
19,551 +17.7%
112.92
US$2,207,761 		19,551 +17.7% 112.92 US$2,207,761
2025-08-14 2025-08-14 B Purchase
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,378 +2.2%
112.12
US$266,613 		2,378 +2.2% 112.12 US$266,613
2025-05-30 2025-05-30 PrS Proposed sale
2.5
VIRGINIA SANZONE

Officer

Officer
700
133.62
US$93,537 		700 133.62 US$93,537
2025-05-30 2025-05-30 S Sale
2.5
Sanzone Virginia Ruth

VP, General Counsel

Officer
700 -9.9%
133.62
US$93,537 		700 -9.9% 133.62 US$93,537
2025-05-28 2025-05-28 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
4,985 -45.0%
128.50
US$640,576 		4,985 -45.0% 128.50 US$640,576
2025-05-28 2025-05-27 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
4,945 -47.3%
131.00
US$647,795 		4,945 -47.3% 131.00 US$647,795
2025-05-23 2025-05-23 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -50.3%
130.00
US$644,670 		4,959 -50.3% 130.00 US$644,670
2025-05-23 2025-05-22 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
4,959 -53.5%
130.03
US$644,832 		4,959 -53.5% 130.03 US$644,832
2025-05-21 2025-05-21 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
4,917 -57.0%
133.00
US$653,961 		4,917 -57.0% 133.00 US$653,961
2025-05-21 2025-05-20 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
4,871 -61.3%
137.11
US$667,879 		4,871 -61.3% 137.11 US$667,879
2025-05-20 2025-05-19 S Sale
3.3
FINNEY ELISHA W
Non-Executive Director
600 -15.6%
138.92
US$83,353 		600 -15.6% 138.92 US$83,353
2025-05-19 2025-05-19 PrS Proposed sale
3.3
FINNEY ELISHA W

Director

Non-Executive Director
600
138.92
US$83,353 		600 138.92 US$83,353
2025-05-19 2025-05-19 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
138.00
US$766,614 		5,555 -69.9% 138.00 US$766,614
2025-05-19 2025-05-16 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
140.00
US$777,700 		5,555 -69.9% 140.00 US$777,700
2025-05-15 2025-05-15 PrS Proposed sale
2.4
Sousa Ben

Officer

Officer
2,000
137.36
US$274,714 		2,000 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
2.4
Sousa Ben

Chief Information Officer

Officer
2,000 -80.7%
137.36
US$274,714 		2,000 -80.7% 137.36 US$274,714
2025-05-15 2025-05-15 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
5,555 -69.9%
135.55
US$752,977 		5,555 -69.9% 135.55 US$752,977
2025-05-15 2025-05-14 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
5,556 -69.9%
138.65
US$770,324 		5,556 -69.9% 138.65 US$770,324
2025-05-14 2025-05-14 PrS Proposed sale
3.4
Voigtlander Christian B.

Officer

Officer
55,556
138.65
US$7,702,684 		55,556 138.65 US$7,702,684
2025-05-13 2025-05-13 PrS Proposed sale
1.8
Greenberg David C.

Director

Non-Executive Director
1,942
143.66
US$278,992 		1,942 143.66 US$278,992
2025-05-13 2025-05-13 S Sale
1.8
Greenberg David C.
Non-Executive Director
1,942 -22.3%
143.66
US$278,992 		1,942 -22.3% 143.66 US$278,992
2025-01-02 2025-01-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
1,373
155.48
US$213,474 		1,373 155.48 US$213,474
2025-01-02 2025-01-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,373 -1.3%
155.48
US$213,474 		1,373 -1.3% 155.48 US$213,474
2024-12-06 2024-12-06 PrS Proposed sale
3.0
Woolson Daniel

Officer

Officer
2,241
156.25
US$350,158 		2,241 156.25 US$350,158
2024-12-06 2024-12-06 S Sale
3.0
Woolson Daniel

VP, GM-Infusion Capital

Officer
2,241 -17.1%
156.25
US$350,158 		2,241 -17.1% 156.25 US$350,158
2024-12-02 2024-12-02 PrS Proposed sale
4.0
VIVEK JAIN

Officer; Director

Executive Director
12,000
162.91
US$1,954,933 		12,000 162.91 US$1,954,933
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
78 -0.1%
163.96
US$12,789 		78 -0.1% 163.96 US$12,789
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
8,250 -7.3%
163.18
US$1,346,223 		8,250 -7.3% 163.18 US$1,346,223
2024-12-02 2024-12-02 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
3,672 -3.1%
162.29
US$595,923 		3,672 -3.1% 162.29 US$595,923
2024-11-27 2024-11-27 PrS Proposed sale
1.8
Greenberg David C.

Director

Non-Executive Director
972
158.11
US$153,683 		972 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
1.8
Greenberg David C.
Non-Executive Director
972 -16.2%
158.11
US$153,683 		972 -16.2% 158.11 US$153,683
2024-11-27 2024-11-27 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
1,430 -100.0%
158.00
US$225,936 		1,430 -100.0% 158.00 US$225,936
2024-11-26 2024-11-26 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
206 -100.0%
160.09
US$32,979 		206 -100.0% 160.09 US$32,979
2024-11-26 2024-11-26 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
7,513 -97.3%
159.09
US$1,195,212 		7,513 -97.3% 159.09 US$1,195,212
2024-11-26 2024-11-25 S Sale
3.4
Voigtlander Christian B.

Chief Operating Officer

Officer
1,962 -100.0%
169.08
US$331,726 		1,962 -100.0% 169.08 US$331,726
2024-11-25 2024-11-25 PrS Proposed sale
3.4
Voigtlander Christian B.

Officer

Officer
11,111
171.00
US$1,899,981 		11,111 171.00 US$1,899,981
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
1,239 -1.2%
173.60
US$215,087 		1,239 -1.2% 173.60 US$215,087
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
2,386 -2.2%
172.76
US$412,212 		2,386 -2.2% 172.76 US$412,212
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,147 -3.7%
171.91
US$712,905 		4,147 -3.7% 171.91 US$712,905
2024-11-04 2024-11-01 PlS Planned sale
4.0
Jain Vivek

Chairman and CEO

Executive Director
4,228 -3.6%
170.75
US$721,933 		4,228 -3.6% 170.75 US$721,933
Explore more

More insider trading research around ICU Medical, Inc.

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America